North American Pharmacist Licensure Examination (NAPLEX) guideStudy & preparation
NAPLEX Biostatistics: Compare Risks and Read Trial Results
Work through a fictional two-group risk comparison, distinguish relative and absolute differences, and read trial clues about allocation, masking, and missing outcomes.
Short answer
For NAPLEX biostatistics, calculate each group's event risk before comparing risks, then examine allocation, masking, and missing outcomes separately. NABP explicitly includes statistical calculations and research design and biostatistics in its content outline, without assigning biostatistics a separate exam percentage. A risk ratio describes the observed comparison but does not, by itself, establish statistical significance or causation.
Where does biostatistics fit on the NAPLEX?
For NAPLEX biostatistics, calculate each group's event risk before comparing risks, then examine allocation, masking, and missing outcomes separately. NABP's content outline names statistical calculations in subdomain 1.C.8 and research design and biostatistics in 1.E.
These topics sit within Foundational Knowledge for Pharmacy Practice. Its 25% weight belongs to the entire domain, not biostatistics alone. The outline effective May 1, 2025, checked November 3, 2026, does not give a separate biostatistics percentage. Use the NAPLEX blueprint and five-domain guide to place this work within the full content outline.
The practice method below combines arithmetic with careful reading. It is Passy's teaching approach, not an NABP-required procedure. The numbers are fictional teaching data; they are not findings from a clinical trial or evidence supporting a treatment.
How do you turn event counts into comparable risks?
Start by naming the endpoint, the groups, and the observation period. Then identify how many participants experienced that endpoint and how many were in each group. Do not divide one group's event count by the other group's total.
Fictional exercise: two groups are followed for the same twelve-month period, with outcomes recorded for everyone. Group A has 200 participants, of whom 20 experience the specified event. Group B also has 200 participants, of whom 40 experience it. Each participant is counted once for whether they experienced the event.
Calculate the two observed risks:
- Group A: 20 ÷ 200 = 0.10 = 10%.
- Group B: 40 ÷ 200 = 0.20 = 20%.
The CDC's archived epidemiology lesson defines a risk ratio, also called relative risk, as the risk in the group of interest divided by the risk in the comparison group. For A compared with B, put A in the numerator:
Risk ratio = risk in A ÷ risk in B = 0.10 ÷ 0.20 = 0.50.
Write a sentence beside the result: “Group A's observed twelve-month risk of the specified event is half Group B's.” That sentence preserves the groups, endpoint, and timeframe. It does not claim that an intervention caused the difference.
Before moving on, cover the answers and set up both risks again. For broader question practice, the full NAPLEX prep planned for launch includes 825 questions across five content domains.
How do relative risk and an absolute risk difference answer different questions?
A risk ratio compares risks by division. An absolute difference compares them by subtraction. In the same fictional exercise, the difference between B's 20% risk and A's 10% risk is:
0.20 − 0.10 = 0.10, or 10 percentage points.
To express the lower observed risk in A as a proportional reduction relative to B, divide that difference by B's risk:
(0.20 − 0.10) ÷ 0.20 = 0.50 = 50%.
This also equals 1 − 0.50 = 0.50, using the A-versus-B risk ratio. The CDC's archived lesson on public health impact supports this mathematical relationship in its vaccine comparison. Here it is applied only to invented arithmetic data, with no claim about an actual vaccine or medicine.
The two correct descriptions are therefore 10 percentage points lower and 50% lower relative to B. Writing “10% lower” without explaining the basis would confuse the absolute difference with the proportional reduction.
Now reverse the comparison. For B compared with A, the risk ratio is 0.20 ÷ 0.10 = 2.00. B's observed risk is twice A's. The data have not changed; the reference group has. Label the numerator and denominator before choosing an answer.
A ratio of 1 indicates equal observed risks; above 1 indicates higher risk in the numerator group, and below 1 indicates lower risk. These statements do not establish statistical significance. Also check the measure's name: an odds ratio, rate ratio, or hazard ratio should not simply be substituted into this risk-ratio calculation.
Keep this exercise separate from mass and concentration problems in the NAPLEX calculations worked-example guide. Your next step is to explain the absolute difference and relative comparison in words without changing the group labels.
What do randomization and blinding tell you?
Treat allocation and masking as separate questions. FDA researchers' poster on open-label trials explains why a design label alone does not settle every possible source of bias. That poster, checked November 3, 2026, is methodological evidence, not a clinical treatment guideline.
Use these prompts as a study worksheet:
- How were participants assigned? Record whether the question states that allocation was randomized. Do not infer randomization merely because two groups are compared.
- Could the assignment be predicted beforehand? Allocation concealment concerns predictability before assignment. Keep this question separate from who knew the assigned group afterward.
- Who knew the assignment? Look for information about participants, treating personnel, and outcome assessors. A general label such as “double-blind” is less useful than an explicit description of who was masked.
- What outcome was measured, and when? Carry the endpoint and timeframe into your interpretation instead of reducing the study to a design label.
- Were outcomes missing or follow-up unequal? Identify what the question tells you and what remains unknown. Either issue can undermine interpretation.
Randomization and masking address different potential biases; neither guarantees a flawless result. Answer the specific question using the stated facts, then identify any conclusion that would require more information.
For short review sessions alongside these written explanations, full NAPLEX prep planned for launch includes 580 flashcards.
Can an open-label trial still have a control group?
Yes. The FDA researchers distinguish open-label design from an uncontrolled or single-arm study. Open-label describes incomplete masking; it does not mean there is no comparison group or no randomization.
Fictional reading exercise: a question describes a randomized, open-label comparison between two groups. Participants and treating personnel know the assignments, while outcome assessors are masked.
What can you record? The study has two comparison groups and randomized assignment. Participants and treating personnel are unmasked; outcome assessors are masked. These features can coexist.
What remains unknown? That description alone does not explain whether allocation was concealed beforehand, how many outcomes were missing, or whether follow-up differed between groups. It also gives no event counts from which to calculate a risk ratio.
The useful next step is to separate a supported statement from an assumption. “Outcome assessors were masked” is supplied by the exercise. “There was no risk of bias” goes beyond it. Do not choose or reject a result solely because the description contains “open-label.”
How do you review a missed study-interpretation question?
Identify the first error in your reasoning and write one correction you can apply to the next problem. Use a short review record:
- Risk setup: Did each event count use its own group's denominator?
- Comparison direction: Did the numerator match the group named in the question?
- Interpretation: Did you distinguish a percentage-point difference from a proportional reduction?
- Design: Did you separate allocation, concealment, and masking?
- Missing information: Did you assume complete outcomes or claim significance without support?
Then redo the problem without looking at the answer. For the numerical exercise above, explain why A-versus-B gives 0.50 while B-versus-A gives 2.00. For the trial exercise, name both the known design features and the unanswered questions.
Use the 20 free NAPLEX practice questions for general practice and the free NAPLEX study plan to make room for focused review. Success on one risk calculation does not predict an exam outcome; the NAPLEX pass rates and passing score guide addresses those separate measures.
When you are ready to combine focused work with a longer practice session, full NAPLEX prep planned for launch includes a 225-question mock exam. Start now by solving the fictional counts again and writing one sentence that states the comparison without claiming more than the data show.
Trust the source
Official sources
Exam policies can change. Use these primary sources for the most current details.
- NAPLEX Content OutlineNational Association of Boards of Pharmacy (NABP)↗
- Principles of Epidemiology: Lesson 3, Section 5 — Measures of AssociationUS Centers for Disease Control and Prevention (CDC)↗
- Principles of Epidemiology: Lesson 3, Section 6 — Measures of Public Health ImpactUS Centers for Disease Control and Prevention (CDC)↗
- Considerations for Open-Label Clinical Trials: Design, Conduct, and AnalysisUS Food and Drug Administration (FDA), Center for Drug Evaluation and Research↗